Similarly, analysis of high-risk neuroblastoma subsets by Larsson et al, showed that high mPGES-1 expression correlated with poor patient survival and that treatment with DCF down-regulated PGE2 and that this correlated with reduced tumour growth volumes in an in vivo murine model [19]. The gene discussed is PTGES; the disease is neoplasm.